18F-sodium fluoride positron emission tomography: an in vivo window into coronary atherosclerotic plaque biology.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder.Frontiers in physiology · 2020
   Review
2. Imaging Cardiovascular Calcification.Journal of the American Heart Association · 2018
   Review
3. Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk.World journal of radiology · 2016
   Article
4. Molecular imaging of coronary atherosclerosis; predictive of an acute myocardial infarction?Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2014
   Article

Corrections and comments

• Comment on
  Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.2012

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as